Track Vitamin Blue's EBIT ($-42K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2018
Trailing 12 months ending Jun 30, 2018
Vitamin Blue posts a EBIT of $-42K as of June 2018. That compares with $-3.9K in the prior-year period — down 955.0% year over year. That is below the sector sector average of $2.4T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Vitamin Blue's EBIT was $-3.9K. The latest reading is $-42K — a 955.0% year-over-year decrease (period ending June 2018). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a EBIT near $2.4T is typical. Vitamin Blue's $-42K is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
EBIT is one piece of Vitamin Blue's financial statement story. At $-42K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for VTMB's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $2.4T), and (3) consistency with growth and profitability. This page covers the first two; Vitamin Blue's other metric pages and overview cover the third.